Cox Proportional Hazards Regression Analysis in Lung Cancer

Author: Amira Mandour
Biostatistician | Clinical Trials & Statistical Modeling Expert

2023-01-03

Objective:

To investigate the impact of various clinical covariates on survival outcomes in patients with advanced lung cancer using Cox proportional hazards regression.

Data:

This study is a clinical trial of lung cancer patients. The dataset includes:

Methodology:

Cox Proportional Hazards Model:

A Cox proportional hazards regression model is built to examine the relationship between survival and clinical covariates. The model estimated hazard ratios (HR) and their 95% confidence intervals (CI) for each covariate.

Covariates Included:

Sex: Gender of the patient (male or female)

Age: Continuous variable representing the patient’s age

ECOG Performance Status: A score representing the patient’s performance status, ranging from 0 (fully active) to 5 (dead)

Physician Karnofsky Score (ph.karno): A measure of the patient’s ability to perform normal daily activities as rated by the physician

Patient Karnofsky Score (pat.karno): A similar measure of the patient’s performance status, but rated by the patient

Weight Loss (wt.loss): A clinical indicator often associated with cancer prognosis

Proportional Hazards Assumption:

The proportional hazards assumption is tested using Schoenfeld residuals. Any covariates that violated this assumption were stratified in subsequent models.

Stratified Cox Model:

For covariates that violated the proportional hazards assumption (e.g., Karnofsky scores), we used stratification to address these violations. Stratification allows the baseline hazard to vary across strata, ensuring valid results despite violations.

Model Evaluation:

The concordance index (C-index) was calculated to assess the model’s ability. The likelihood ratio test, Wald test, and score test were conducted to evaluate the overall significance of the model.

Results:

Cox Proportional Hazards Regression Model

A Cox proportional hazards regression model was fitted to assess the impact of various clinical and demographic factors on survival in lung cancer patients. The following variables were included in the model: Age, ECOG performance status (ph.ecog), Karnofsky performance score (ph.karno), and patient Karnofsky score (pat.karno).

Model Results:

Cox Model for Survival Outcomes: A Multivariable Analysis of Lung Cancer Prognostic Factors
Characteristic Hazard Ratio (HR)1,2 95% CI2 P value3
Sex 0.57 0.41, 0.80 0.001
Age (years) 1.01 0.99, 1.03 0.2
ECOG performance status 1.76 1.22, 2.54 0.002
Physician Karnofsky score 1.02 1.00, 1.04 0.11
Patient Karnofsky score 0.99 0.98, 1.00 0.14
1 HRs are adjusted for all variables included in the model.
2 HR = Hazard Ratio, CI = Confidence Interval
3 P values are from the Wald test.

Overall Model Fit and Significance:

Evaluation of Proportional Hazards Assumption:

The proportional hazards assumption (PHA) was evaluated for the variables included in the Cox proportional hazards regression model using Schoenfeld residuals. The results of the Schoenfeld residuals test for each covariate, as well as the global test, are summarized below.

Schoenfeld Residuals Test for Proportional Hazards Assumption
Covariate Chi-Square df p-value
Sex 1.704 1 0.19
Age 0.001 1 0.97
ECOG Performance Status 2.040 1 0.15
Physician Karnofsky Score (ph.karno) 5.411 1 0.02
Patient Karnofsky Score (pat.karno) 4.737 1 0.03
Global Test 9.229 5 0.10

The proportional hazards assumption was satisfied for most variables in the model, as indicated by the p-values of sex, age, and ECOG performance status, which were all greater than 0.05. However, there is evidence of a violation of the proportional hazards assumption for physician Karnofsky score (ph.karno) and patient Karnofsky score (pat.karno) (p-values 0.02 and 0.03, respectively). These findings suggest that the effects of these two variables on survival may change over time, and further analysis, such as including time-varying covariates for these variables, may be required.

Schoenfeld Residuals for Assessing the Proportional Hazards Assumption:

We fitted a Cox proportional hazards regression model to assess the impact of clinical variables on survival, stratifying by Physician Karnofsky Score (ph.karno) and Patient Karnofsky Score (pat.karno) to account for potential violations of the proportional hazards assumption for these variables.

Key Results:

Cox Proportional Hazards Regression Model (Stratified) Results After Addressing Proportional Hazards Violations
Covariate Coefficient (ß) Hazard Ratio (HR) Confidence Interval p-value
95% CI (Lower) 95% CI (Upper)
Sex −0.638 0.528 0.356 0.784 0.002
Age 0.015 1.016 0.993 1.038 0.171
ph.ecog 0.329 1.389 0.852 2.265 0.188

Model Evaluation:

Discussion:

This Cox regression model confirms the well-established associations between clinical factors (such as performance status and sex) and survival outcomes in lung cancer patients. The findings highlight the importance of gender differences in survival and the significant role of ECOG performance status in predicting patient prognosis. Furthermore, the use of stratification for Karnofsky scores ensured valid results despite the violations of the proportional hazards assumption for these variables.

Conclusion:

In this study, sex and performance status (ECOG) were identified as significant predictors of survival in patients with advanced lung cancer. The use of Cox regression, with appropriate adjustments for assumption violations, provided valuable insights into the factors influencing survival outcomes.

Cox proportional hazards regression analysis identified ECOG performance status and gender as significant predictors of survival, consistent with prior studies that have emphasized the importance of functional status in lung cancer prognosis.